HIV-infection has no prognostic impact on advanced-stage classical Hodgkin lymphoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  AIDS (London)

• Publication date

  2017-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0000000000001487PMID 28574963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

  2017cited by this paper
• High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

  2015cited by this paper
• Prognostic factors for advanced‐stage human immunodeficiency virus‐associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi‐institutional retrospective study

  2015cited by this paper
• How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

  2015cited by this paper
• HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

  2012cited by this paper
• Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.

  2012cited by this paper
• Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2011cited by this paper
• Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

  2009cited by this paper
• Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.

  2007cited by this paper
• Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

  2006cited by this paper
• Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study.

  2006cited by this paper
• Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149).

  2000cited by this paper

• A national, multicenter, retrospective study of human immunodeficiency virus infection-associated lymphoma in China

  2025cites this paper
• Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study

  2024cites this paper
• Diarrhea as the Initial Presentation in a Patient With HIV Diagnosed With Hodgkin’s Lymphoma

  2024cites this paper
• Enabling CAR T‐cell therapies for HIV‐positive lymphoma patients – A call for action

  2023cites this paper
• A Rare Case of Good Outcome of Hodgkin Lymphoma in a Patient with HIV on Antiretroviral Therapy (ART)

  2022cites this paper
• Hodgkin Lymphoma in People Living with HIV

  2021influential citation
• Immunodeficiency-associated Hodgkin lymphoma

  2021cites this paper
• Outcomes of Treatment for HIV-Infected Lymphoma Patients: A National Cancer Database (NCDB) Analysis.

  2020cites this paper
• Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

  2020cites this paper
• Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection

  2018cites this paper
• 18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma

  2018cites this paper
• HIV positivity may not have a negative impact on survival in Epstein-Barr virus-positive Hodgkin lymphoma: A Japanese nationwide retrospective survey.

  2018cites this paper
• Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma

  2017cites this paper
• The influence of antiretroviral therapy on clinical aspects of HIV-related lymphoma.

  2017cites this paper